Genmab A/S (NASDAQ:GMAB) Stock Rating Lowered by Sanford C. Bernstein
Genmab A/S (NASDAQ:GMAB – Get Free Report) was downgraded by analysts at Sanford C. Bernstein from a “market perform” rating to an “underperform” rating in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. GMAB has been the subject of several other reports. Truist Financial reduced their price objective on Genmab A/S […]
Genmab A/S (NASDAQ:GMAB – Get Free Report) was downgraded by analysts at Sanford C. Bernstein from a “market perform” rating to an “underperform” rating in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. GMAB has been the subject of several other reports. Truist Financial reduced their price objective on Genmab A/S […]
